Immunogen, Inc. Community Page | What other sites are saying about Immunogen, Inc.

Immunogen, Inc.

(NQ: IMGN)

16.29 USD +0.21 (+1.31%)

Official Closing Price / Updated: 8:10 PM EDT, May 17, 2013 / Add to My Watchlist

(IMGN) Community Analysis from

READ MORE (IMGN)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 18, 2013

(IMGN) ImmunoGen to Focus on Pipeline

(Stock Blog Hub, 4/27/13)

ImmunoGen Inc.(IMGN) recently provided an update on its pipeline and maintained its outlook for fiscal year 2013 (ending June 30) at its recently held Analyst & Investor Day. ImmunoGen...(read more)

How To Profit From An Alternative To Chemotherapy

(Penny Sleuth, 8/20/12)

Over a year ago, I told you about two companies pioneering a new therapeutic platform that provides the benefits of chemotherapy while reducing the side effects. Many of you are familiar with the...(read more)

These New Poisonous Drugs Are Deadly to Cancer

(Wall Street Daily, 8/31/11)

Last week, I mentioned how the Institute of Cancer Research recently discovered the driving force behind cancer’s ability to spread. And a drug that would potentially stop...(read more)

View all posts about ImmunoGen (IMGN)

ImmunoGen (IMGN) Company Overview

There is no analysis for IMGN yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates